Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
-
Canaccord Genuity Reiterates Buy Rating on Verve Therapeutics (VERV)
-
Canaccord Genuity Reiterates Buy Rating on Holley (HLLY)
-
Intuitive Machines Inc. (LUNR) PT Lowered to $21 at Canaccord Genuity
-
Dragonfly Energy Corp. (DFLI) PT Raised to $3 at Canaccord Genuity
-
Middlefield Canadian Income PCC - Annual Financial Report
-
Valeura Energy Inc. Announces Another Year of Record Results in 2024
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA), 'estimate 1Q25 deliveries are mostly being impacted by supply constraints'
-
eToro Group (ETOR) Files Registration Statement for Proposed Initial Public Offering
-
eToro Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Canaccord Genuity Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
-
Strategy (MSTR) acquired approximately 6,911 more bitcoins
-
Elicio Therapeutics (ELTX) Appoints Preetam Shah as Chief Strategy and Financial Officer
-
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
-
Canaccord Genuity Reiterates Hold Rating on Akoya Biosciences Inc (AKYA)
-
Thor Explorations Announces Drilling Results and Update on the Douta Gold Project, Senegal
-
Form 8.3 - [ALLIANCE PHARMA PLC - 20 03 2025] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Pulmonx Corp. (LUNG)
-
TELA Bio, Inc. (TELA) PT Lowered to $7 at Canaccord Genuity
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $390 at Canaccord Genuity
-
Alarum Technologies (ALAR) PT Lowered to $11 at Canaccord Genuity
-
Canaccord Genuity Downgrades Knight Therapeutics Inc. (GUD:CN) (KHTRF) to Hold
-
Canaccord Genuity Starts Apiam Animal Health (AHX:AU) at Buy
-
Notice of Results and Investor Presentation
-
Dakota Gold Announces Pricing of Offering of Common Stock for Gross Proceeds of Approximately $35 Million
-
Liberty Announces Closing of Prospectus Offering of Units
-
Orezone Gold Reports Record Revenue and Net Income for 2024
-
Canaccord Genuity Upgrades Nanosonics Limited (NAN:AU) (NNCSF) to Buy
-
C3 Metals Announces Closing of $11,500,000 Bought Deal Private Placement
-
Canaccord Genuity Reiterates Buy Rating on Alphabet (GOOGL)
-
Canaccord Genuity Downgrades RioCan REIT (REI-U:CN) (RIOCF) to Hold
-
Canaccord Genuity Reiterates Hold Rating on Yeti Holdings Inc. (YETI)
-
Quanterix Corp. (QTRX) PT Lowered to $15 at Canaccord Genuity
-
Canaccord Genuity Starts Fonix Plc (FNX:LN) at Buy
-
Lithium Royalty Corp. Announces 81% Growth in LCEts for 2024 in First Full Calendar Year as a Public Company; Mariana Lithium Project Inaugurated in 1Q25
-
Strategy (MSTR) acquired approximately 130 more bitcoins for $10.7 million
-
Bridger Aerospace (BAER) PT Lowered to $5 at Canaccord Genuity
-
BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement
-
Form 8.3 - [THRUVISION GROUP PLC - 13 03 2025] - (CGAML)
-
Canaccord Assumes Peloton (PTON) at Buy, 'regains its footing and poised to benefit as a leader in connected fitness'
-
ULTA Beauty (ULTA) PT Lowered to $526 at Canaccord Genuity
-
Spire Global (SPIR) PT Lowered to $14.50 at Canaccord Genuity
-
PagerDuty (PD) PT Lowered to $23 at Canaccord Genuity
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 12 03 2025] - (CGWL)
-
Form 8.3 - [THRUVISION GROUP PLC - 12 03 2025] - (CGAML)
-
Form 8.3 - [ALLIANCE PHARMA PLC - 12 03 2025] - (CGWL)
-
Rep Data Secures Growth Investment to Advance Technology Innovation Across the Insights Industry
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Canaccord Genuity
-
Voyager Therapeutics (VYGR) PT Lowered to $12 at Canaccord Genuity

